32 reports

  • 8.5 ABBVIE

The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA, an oral therapy for the treatment of patients with chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, f

  • Genetic Disorder
  • World
  • Market Size
  • AbbVie Inc.
  • Editas Medicine, Inc.

The offers a wide range of devices and kits for autoimmune diseases worldwide.

  • Endoscope
  • Endoscopic Device
  • World
  • Forecast
  • Smith & Nephew Plc

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • East Asia
  • Japan
  • Forecast
  • Olympus Corporation

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • Brazil
  • South America
  • Forecast
  • Medtronic, Inc.

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • Latin America
  • Mexico
  • North America
  • Forecast

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • Australasia
  • Australia
  • Oceania
  • Forecast

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • China
  • East Asia
  • Forecast
  • Olympus Corporation

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • India
  • South Asia
  • Forecast
  • Olympus Corporation

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • Italy
  • Southern Europe
  • Forecast
  • Olympus Corporation

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • Eastern Europe
  • Russia
  • Forecast
  • Medtronic, Inc.

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • East Asia
  • South Korea
  • Forecast
  • Olympus Corporation

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • Southern Europe
  • Spain
  • Forecast
  • Olympus Corporation

Engages in the development of drugs for hematologic, autoimmune, and neurological disorders.

  • Genetic Disorder
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Octapharma AG Clinical Trial Overview of Octapharma AG

IT WAS UNDER DEVELOPMENT FOR THE TREATMENT OF ALZHEIMER' S DISEASE (AD).

  • Genetic Disorder
  • World
  • Baxter International Inc.
  • Biotest AG
  • CSL Limited

It is one of the most common types of genetic diseases observed in Caucasian children.

  • Genetic Disorder
  • Europe
  • Actavis plc
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.

The drug candidate is a modified alpha cobratoxin developed for autoimmune diseases.

  • Genetic Disorder
  • World
  • Aldagen, Inc.
  • Asklepion Pharmaceuticals, LLC
  • Nutra Pharma Corporation

The autoimmune disease affects about ##% of the population and is caused by alimentary gluten in genetically susceptible individuals.

  • Genetic Disorder
  • Germany
  • World
  • Product Initiative
  • Zedira GmbH

She was subsequently appointed President and Chief Executive Officer for Lycera Corp., a biopharmaceutical company pioneering innovative approaches to novel oral medicines for treatment of autoimmune diseases and cancer.

  • Asthma
  • Genetic Disorder
  • Pharmaceutical
  • United States
  • Pharmaxis Ltd
  • R&D Progress
  • PRIMARY IMMUNE DEFICIENCY (PID) - PIPELINE BY OCTAPHARMA AG, H1 2018

THE COMPANY DEVELOPS PRODUCTS FOR FIBROSIS, ANEMIA, AUTOIMMUNE DISEASES, INFLAMMATION, AND NEPHROPATHIES.

  • Blood Supply
  • Genetic Disorder
  • Infectious Disease
  • Therapy
  • ADMA Biologics, Inc.

The autoimmune disease affects about ##% of the population and is caused by alimentary gluten in genetically susceptible individuals.

  • Genetic Disorder
  • Therapy
  • World
  • Product Initiative
  • Zedira GmbH
  • PRIMARY IMMUNE DEFICIENCY (PID) - PIPELINE BY SANGAMO THERAPEUTICS INC, H2 2017
  • PRIMARY IMMUNE DEFICIENCY (PID) - PIPELINE BY PROMETIC LIFE SCIENCES INC, H2 2017

The company develops products for fibrosis, anemia, autoimmune diseases, inflammation, and nephropathies.

  • Genetic Disorder
  • Infectious Disease
  • Therapy
  • United States
  • Product Initiative

NESTLE WILL LEAD SANOFI S RESEARCH EFFORTS TO BUILD A ROBUST AND INNOVATIVE EARLY PORTFOLIO IN IMMUNOLOGY AND INFLAMMATION, HELPING THE COMPANY ACHIEVE A LEADERSHIP POSITION IN CRITICAL AREAS SUCH AS CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASE.

  • Body Contouring Device
  • Endoscope
  • France
  • Western Europe
  • Forecast

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Biopsy
  • Endoscope
  • Germany
  • Western Europe
  • Forecast

On May ##, 2015; August ##, 2015 and December ##, 2015 the agreement was amended.

  • Genetic Disorder
  • Therapy
  • United States
  • Company
  • Proteostasis Therapeutics, Inc.

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • Hospital
  • Northern Europe
  • United Kingdom
  • Forecast
  • CYSTIC FIBROSIS - PIPELINE BY PROGENRA INC, H2 2017
  • SMALL MOLECULES FOR CYSTIC FIBROSIS

OSE' s Effi-## is in preclinical development and targets autoimmune diseases and transplantation.

  • Genetic Disorder
  • United States
  • Company
  • Product Initiative
  • Galapagos NV
  • CYSTIC FIBROSIS - PIPELINE BY INVION LTD, H1 2018
  • CYSTIC FIBROSIS - PIPELINE BY INSMED INC, H1 2018

The company develops gene therapies for cardiovascular, respiratory, autoimmune, ophthalmologic diseases, and cancer.

  • Genetic Disorder
  • United States
  • Company
  • Product Initiative
  • Galapagos NV

May ##, 2012 Galapagos NV initiated its second Phase IIa clinical study with GLPG##, a new Janus kinase ## (JAK##) inhibitor being developed to treat multiple autoimmune diseases, such as rheumatoid arthritis (RA).

  • Genetic Disorder
  • Therapy
  • World
  • Product Initiative
  • Galapagos NV

It focuses on therapy areas such as respiratory, inflammation, autoimmune disease (RIA); cardiovascular and metabolic disease (CVMD); and cancer, besides infection and neurological diseases.

  • Antibiotic Resistance
  • Genetic Disorder
  • United States
  • Product Initiative
  • Insmed Incorporated

Teva manufactures specialty pharmaceuticals for the treatment of disorders such as multiple sclerosis, Parkinson' s disease, autoimmune diseases, cancer and pain management.

  • Analgesic
  • Endoscope
  • North America
  • United States
  • Forecast